These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2517343)

  • 1. Established facts, doubts and future perspectives on PGI2 vascular and platelet receptors.
    Giovanazzi S; Oliva D; Lograno MD; Corsini A; Fumagalli R; Nicosia S
    Pharmacol Res; 1989; 21 Suppl 1():83-4. PubMed ID: 2517343
    [No Abstract]   [Full Text] [Related]  

  • 2. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
    Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
    Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostacyclin-sensitive adenylate cyclase and prostacyclin binding sites in platelets and smooth muscle cells.
    Nicosia S; Oliva D; Bernini F; Fumagalli R
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():593-9. PubMed ID: 6328938
    [No Abstract]   [Full Text] [Related]  

  • 4. PGI2 receptors in vasculature and platelets: 5Z-carbacyclin discriminates between them.
    Nicosia S; Oliva D; Noè MA; Corsini A; Folco GC; Fumagalli R
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():474-8. PubMed ID: 2959100
    [No Abstract]   [Full Text] [Related]  

  • 5. PGI2-receptors and molecular mechanisms in platelets and vasculature: state of the art.
    Oliva D; Nicosia S
    Pharmacol Res Commun; 1987 Nov; 19(11):735-65. PubMed ID: 3328202
    [No Abstract]   [Full Text] [Related]  

  • 6. (5Z)-carbacyclin discriminates between prostacyclin-receptors coupled to adenylate cyclase in vascular smooth muscle and platelets.
    Corsini A; Folco GC; Fumagalli R; Nicosia S; Noe MA; Oliva D
    Br J Pharmacol; 1987 Jan; 90(1):255-61. PubMed ID: 3545351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (5Z)-carbacyclin displays agonist-antagonist properties on prostacyclin-receptors in platelets and vascular myocytes.
    Corsini A; Oliva D; Folco GC; Giovanazzi S; Noe' MA; Fumagalli R; Nicosia S
    Biomed Biochim Acta; 1988; 47(10-11):S104-7. PubMed ID: 3073757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptors for PGI2 and PGD2 on human platelets.
    Siegl AM
    Methods Enzymol; 1982; 86():179-92. PubMed ID: 6290840
    [No Abstract]   [Full Text] [Related]  

  • 9. Human prostacyclin platelet receptors in diabetes mellitus.
    Modesti PA; Fortini A; Gensini GF; Vanni D; Prisco D; Abbate R
    Thromb Res; 1991 Sep; 63(5):541-8. PubMed ID: 1755006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The presence of leukotriene C4- and prostacyclin-binding sites in nonpregnant human uterine tissue.
    Chegini N; Rao CV
    J Clin Endocrinol Metab; 1988 Jan; 66(1):76-87. PubMed ID: 2826530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human prostacyclin platelet receptors and platelet lipid composition.
    Modesti PA; Abbate R; Prisco D; Gensini GF
    J Lipid Mediat; 1990; 2(6):309-15. PubMed ID: 2133274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eicosanoids of platelets and vascular wall in chronic renal insufficiency.
    Sinzinger H; Leithner C
    Am J Nephrol; 1987; 7(3):212-20. PubMed ID: 3115103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin I2 receptors in a particulate fraction of platelets of various species.
    Schillinger E; Prior G
    Biochem Pharmacol; 1980 Sep; 29(17):2297-9. PubMed ID: 6252899
    [No Abstract]   [Full Text] [Related]  

  • 14. Reduction in prostacyclin platelet receptors in active spontaneous angina.
    Neri Serneri GG; Modesti PA; Fortini A; Abbate R; Lombardi A; Gensini GF
    Lancet; 1984 Oct; 2(8407):838-41. PubMed ID: 6148573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refractoriness of platelets to prostaglandins after infusion in rabbits.
    Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
    J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin does not interfere with prostacyclin and prostaglandin D2 binding to platelets.
    Fortini A; Modesti PA; Abbate R; Gensini GF; Neri Serneri GG
    Thromb Res; 1985 Nov; 40(3):319-28. PubMed ID: 3001968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonistic action of AA-2414 on thromboxane A2/prostaglandin endoperoxide receptor in platelets and blood vessels.
    Imura Y; Terashita Z; Shibouta Y; Inada Y; Nishikawa K
    Jpn J Pharmacol; 1990 Jan; 52(1):35-43. PubMed ID: 2137886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for distinct prostaglandin I2 and D2 receptors in human platelets.
    Miller OV; Gorman RR
    J Pharmacol Exp Ther; 1979 Jul; 210(1):134-40. PubMed ID: 221643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of stable prostaglandins to investigate prostacyclin (PGI2)-binding sites and PGI2-sensitive adenylate cyclase in human platelet membranes.
    Lombroso M; Nicosia S; Paoletti R; Whittle BJ; Moncada S; Vane JR
    Prostaglandins; 1984 Feb; 27(2):321-33. PubMed ID: 6326201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unidirectional transfer of prostaglandin endoperoxides between platelets and endothelial cells.
    Schafer AI; Crawford DD; Gimbrone MA
    J Clin Invest; 1984 Apr; 73(4):1105-12. PubMed ID: 6423665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.